U.S. Markets closed

Allergan plc (AGN)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
193.02+0.03 (+0.02%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close192.99
Open193.01
Bid0.00 x 900
Ask0.00 x 1100
Day's Range191.64 - 193.37
52 Week Range158.67 - 202.21
Volume12,447,853
Avg. Volume12,442,653
Market Cap63.659B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateAug 04, 2020 - Aug 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est188.33
  • Moody's

    Almirall, S.A. -- Moody's announces completion of a periodic review of ratings of Almirall, S.A.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Almirall, S.A. Paris, August 11, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Almirall, S.A. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • AbbVie Joins The Coronavirus Drug Hunt — Is AbbVie Stock A Buy?
    Investor's Business Daily

    AbbVie Joins The Coronavirus Drug Hunt — Is AbbVie Stock A Buy?

    AbbVie stock broke out in April and the pharmaceutical company just wrapped its acquisition of Allergan. Further, AbbVie is collaborating on a coronavirus drug. Is AbbVie stock a buy now?

  • /R E P E A T -- New Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical Development/
    CNW Group

    /R E P E A T -- New Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical Development/

    TORONTO , June 17, 2020 /CNW/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (SPOR.CN) (0XM2.F) (TRMND), an investment issuer focused on emerging sectors including the psychedelic sector, is pleased to announce that it has welcomed Dr. Carolyn Myers , Ph.D. to provide business strategy and business development consulting services to the Company. Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading health care businesses.